The BRAVE Study tested the best way to measure treatment quality during exposure therapy, for therapists treating children and young adults with anxiety. As part of this study, researchers provided exposure therapy training for therapists at Riverside Community Care. Children were asked to participate in this study to help test a new tool to better understand different things that happen during exposure therapy to make it more or less effective.

A child anxiety assessment study where children ages 8 to 12 received an anxiety evaluation and participated in observations of family processes. We are interested in seeing how anxious children and their mothers talk about problems and interact in different situations.  

A brief study to learn from parents about finding an exposure therapist. We wanted to know what things got in the way and what things helped them find treatment for their child.

This was a treatment study for children and adolescents (ages 7-17) with OCD, who still had symptoms after pharmacological treatment with a selective serotonin reuptake inhibitor (SSRI). This study investigated the addition of CBT for those who partially responded to therapy with an SSRI alone. 

This collaborative, multi-site study with Duke University Medical Center and the University of Pennsylvania School of Medicine tested a family-based Cognitive Behavioral Treatment manual against a family-based Relaxation Therapy manual for 5 through 8-year-old children with OCD.

This multi-site treatment study evaluated the effectiveness of CBT alone, selective serotonin reuptake inhibitor (SSRI) alone, and combined CBT and SSRI treatment for children and adolescents (ages 7-17) with OCD. Results showed that children and adolescents with OCD should begin treatment with CBT alone or a combination of CBT and an SSRI.